This week’s bulletin explains
the acronym ‘SAMe-TT2R2’, the
clinical measure by which effective
anticoagulation with Vitamin
K antagonists (i.e. warfarin)
is determined, maintaining
International Normalised Ratio
(INR) within therapeutic range.
A distinction is drawn between
the value of the acronym for
warfarin patients versus those
prescribed the novel anticoagulants
(NOACs).The above article was sent to subscribers in Pharmacy Daily's issue from 25 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Aug 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.